IMMUNIC, INC. — Director's Dealing 2022

Nov 8, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IMMUNIC, INC. (IMUX)
CIK: 0001280776
Period of Report: 2022-11-07

Reporting Person: Whaley Glenn (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-11-07	Common Stock	P	5000	$1.495	Acquired	20510	Direct

Footnotes

F1: Includes a purchase of 2,568 shares on 11/30/21 and 2,942 shares on 5/31/22 under the IMUX employee stock purchase plan.